Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Immunopharma AS

Closing information (x1000 SEK)

Closing information 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Turnover 509,602 Less Arrow 400,697 Less Arrow 302,199
Financial expenses 10,279 Less Arrow 10,223 More Arrow 11,242
Earnings before taxes -52,564 More Arrow -23,858 More Arrow -18,677
Total assets 402,957 Less Arrow 360,163 More Arrow 373,401
Current assets 243,058 Less Arrow 135,325 Less Arrow 99,276
Current liabilities 113,001 Less Arrow 76,355 Less Arrow 68,694
Equity capital 216,132 More Arrow 250,139 Less Arrow 131,751
- share capital 14,658 Less Arrow 13,718 Less Arrow 9,942
Employees (average) 8 Less Arrow 1

Financial ratios

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Solvency 53.6% More Arrow 69.5% Less Arrow 35.3%
Turnover per employee 50,087 More Arrow 302,199
Profit as a percentage of turnover -10.3% More Arrow -6.0% Less Arrow -6.2%
Return on assets (ROA) -10.5% More Arrow -3.8% More Arrow -2.0%
Current ratio 215.1% Less Arrow 177.2% Less Arrow 144.5%
Return on equity (ROE) -24.3% More Arrow -9.5% Less Arrow -14.2%
Change turnover 96,489 Less Arrow 76,070 More Arrow 299,968
Change turnover % 23% Equal arrow 23% More Arrow 13447%
Chg. No. of employees 7 Less Arrow 0
Chg. No. of employees % 700% Less Arrow 0%

Total value of public sale

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.